Pear Therapeutics Funding & Investors
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
peartherapeutics.comTotal Amount Raised: $409,000,000
Pear Therapeutics Funding Rounds
Post Ipo Equity
$125,000,000
Post Ipo Equity Investors
Neuberger BermanSoftBank Investment Advisers5am VenturesSarissa Capital ManagementThe Eleven FundQUAD Investment ManagementArboretum VenturesPritzker Vlock Family OfficeHealth Innovation CapitalShandadRx CapitalJAZZ Venture PartnersForth ManagementBlue Water Life Science FundTemasekPilot House VenturesPalantir CapitalTrustbridge PartnersSeries D
$20,000,000
Series D
$80,000,000
Series D Investors
SoftBank Investment AdvisersEDBI5am VenturesSarissa Capital ManagementQUAD Investment ManagementArboretum VenturesNovartisCrimsonox CapitalShandaJAZZ Venture PartnersForth ManagementTemasekPilot House VenturesDebt Financing
$50,000,000
Debt Financing Investors
Perceptive AdvisorsSeries C
$64,000,000
Series C Investors
Arboretum VenturesNovartisBridge Builders CollaborativeEDBIJAZZ Venture Partners5am VenturesBlue Water Life Science FundTemasekTrustbridge PartnersSeries B
$50,000,000
Series B Investors
NovartisArboretum VenturesBridge Builders CollaborativedRx CapitalEDBIJAZZ Venture Partners5am VenturesTemasekSeries A
$20,000,000
Series A Investors
Arboretum VenturesNovartisBridge Builders CollaborativeJAZZ Venture Partners5am Ventures
Funding info provided by Diffbot.